-
Sponsored by Gorodissky & PartnersVladimir Biriulin of Gorodissky & Partners explains why the patent office and the chamber were not satisfied with an applicant’s attempts to trademark a blue bottle -
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners considers the findings of a study into the increasing importance of standard essential patents and their licensing in Japan
-
Sponsored by Bugnion SpAMarco Lissandrini of Bugnion likens the decision in G1/19 to a round of golf, explaining the three-step pattern of reasoning to assess inventiveness
-
Sponsored by Gün + PartnersUğur Aktekin and Begüm Soydan of Gün and Partners explain why the Court of Cassation’s decision has evoked a mixed reaction from trademark filers
-
Sponsored by OLIVARESDiego Ballesteros of OLIVARES examines the evolving law of declaring trademarks in Mexico
-
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners takes a closer look at how the Japanese government’s approach to the strategic acquisition and utilisation of SEPs will change
-
Sponsored by Vivien Chan & CoExperts from Vivien Chan & Co report on significant developments from the IP world across China and the Asia-Pacific
-
Sponsored by AJ ParkAJ Park explains the key takeaways from a recent case involving trademark disclaimers
-
Sponsored by Bird & BirdPeter Brownlow and Mark Hilton of Bird & Bird consider the impact of Brexit on international IP cases heard in England
-
Sponsored by LexOrbisManisha Singh and Simran Bhullar of LexOrbis take a look at the surprising court record of a persistent offender deceptively targeting Indian health and beauty brands
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law summarises the eligible drugs, the re-examination period and strategies available for companies
-
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners previews potential suggested changes to Japan’s patent world
